The current fundraising initiative of the National Women’s Division of the Albert Einstein College of Medicine supports research in Women’s Health and Cancers. The funds raised will support cutting-edge basic and translational research studies focusing on cancers that affect women -- including gynecological cancers (ovarian, cervical and uterine) and breast cancer.
These collaborative studies are being conducted by leading scientists from virtually all disciplines and academic departments at Einstein who are members of the Albert Einstein Cancer Center (AECC).
Under the leadership of AECC Director I. David Goldman, M.D., the Susan Resnick Fisher Professor, these research studies are aimed at the discovery of new and innovative treatments, prevention strategies and, ultimately, cures for women’s cancers. Established in 1970, the AECC was designated as a National Cancer Institute (NCI)-funded center in 1972 and has received continuous funding from the NCI since that time. Marilyn Resnick Katz, a past president of the Westchester/Fairfield Chapter of the Women’s Division and a current member of the division’s national board, is the founding chairperson of the Cancer Research Advisory Board of the AECC.